Comparative Analysis of Duodenum-Preserving Pancreatic Head Resection and Pancreaticoduodenectomy

0
1
0

Comparative Analysis of Duodenum-Preserving Pancreatic Head Resection and Pancreaticoduodenectomy

If you or a loved one has a benign or slow-growing tumor in the pancreatic head—such as chronic pancreatitis or a solid-pseudopapillary tumor—you may face a tough choice: undergo a major surgery that removes the duodenum (the first part of the small intestine) or a more targeted procedure that saves this critical organ. For years, doctors have debated which option is safer, cheaper, and better for long-term quality of life. A 2020 study from the First Affiliated Hospital of Xinjiang Medical University sheds new light on this question—and the results favor the duodenum-sparing approach.

Study Overview

Researchers led by Yong-Hui Sun, Nan Ding, and Qi-Long Chen (from the Department of Pancreas Surgery and Pharmacy at the First Affiliated Hospital of Xinjiang Medical University) compared two surgical techniques for pancreatic head diseases: duodenum-preserving pancreatic head resection (DPPHR) and pancreaticoduodenectomy (PD, or the Whipple procedure). Their goal was to see which method offered better outcomes for patients with benign or low-grade malignant conditions—a group where preserving quality of life is just as important as removing disease.

What Are DPPHR and PD?

PD is a well-known but invasive surgery: it removes the pancreatic head, duodenum, part of the stomach, and the common bile duct. To restore digestion, surgeons reattach the remaining pancreas, bile duct, and stomach to the small intestine. While effective for cancer, PD often leads to long-term digestive problems because the duodenum (which mixes food with pancreatic enzymes and bile) is gone.

DPPHR is a newer, gentler alternative. It removes the diseased part of the pancreatic head but saves the duodenum. There are three common versions (Beger, Berne, and Frey), but all focus on preserving the duodenum to protect digestion. For example, the Beger technique removes most of the pancreatic head but leaves a thin rim of tissue attached to the duodenum, then reconnects the remaining pancreas to the small intestine.

How the Study Was Done

The team analyzed data from 86 patients who underwent either DPPHR (29 patients) or PD (57 patients) between 2014 and 2018. They only included patients with benign or low-grade malignant pancreatic head diseases (like chronic pancreatitis, mucinous cystic tumors, or pancreatic neuroendocrine tumors) and excluded anyone with high-grade cancer, previous pancreatic surgery, or incomplete medical records.

Follow-up lasted at least one year, with:

  • Outpatient visits and imaging (CT, MRI, ultrasound) every 3 months.
  • Quality-of-life surveys using the EORTC QLQ-C30—a validated tool used worldwide to measure how cancer treatments affect physical, emotional, and social well-being.
  • Nutritional assessments with the Nutrition Risk Screening 2002 tool.

Key Results: DPPHR Is Better for Eligible Patients

The data showed DPPHR had clear advantages over PD:

  1. Shorter surgeries and hospital stays: DPPHR operations took 107 fewer minutes (average 493 vs. 600 minutes) and patients went home 7 days earlier (25 vs. 31 days).
  2. Lower costs: DPPHR cost 34,000 RMB less (about $14,000 vs. $19,000 USD at 2020 rates).
  3. Fewer complications: Only 7% of DPPHR patients developed pancreatic exocrine insufficiency (when the pancreas can’t make enough digestive enzymes) compared to 37% of PD patients. They also had 30% fewer long-term complications (35% vs. 65% for PD).
  4. Better nutrition and quality of life: DPPHR patients kept more weight (median 3 kg vs. 0 kg for PD) and reported significantly better overall health on the QLQ-C30 survey one year post-surgery. This means they felt more energetic, had less pain, and enjoyed a better social life.

Why DPPHR Works: The Duodenum Matters

The biggest difference between the two surgeries is the duodenum. When it’s preserved (DPPHR), the body can still:

  • Mix food with pancreatic enzymes and bile for proper digestion.
  • Absorb nutrients like fat, protein, and vitamins.
  • Maintain normal bowel function.

PD removes the duodenum, which disrupts this process. Patients often struggle with weight loss, diarrhea, and fatigue—all of which hurt their quality of life. DPPHR avoids these issues by keeping the duodenum intact.

Who Should Get DPPHR?

DPPHR is not for high-grade pancreatic cancer—PD is still the gold standard for removing cancerous tissue. But for patients with:

  • Chronic pancreatitis
  • Pancreatic pseudocysts
  • Serous/mucinous cystic tumors
  • Solid-pseudopapillary tumors
  • Pancreatic neuroendocrine tumors (low-grade)

DPPHR is a safer, more effective option.

What This Means for Patients

If you have a benign or low-grade malignant pancreatic head disease, talk to your surgeon about DPPHR. The study shows it’s:

  • Safer: Fewer complications and shorter recovery.
  • Cheaper: Lower hospital costs.
  • Better for quality of life: You’ll keep more weight, have fewer digestive issues, and feel better overall.

Conclusion

For eligible patients, DPPHR is a game-changer. It offers the same disease control as PD but with fewer side effects, lower costs, and a better quality of life. As more surgeons adopt this technique, patients with benign or low-grade pancreatic head diseases can look forward to a faster, easier recovery.

This analysis is based on a study published in Chinese Medical Journal (2020) by Yong-Hui Sun, Nan Ding, Kun Cheng, Hai Lin, Jia-Qi Xu, and Qi-Long Chen. The full study is available at doi.org/10.1097/CM9.0000000000000968

Was this helpful?

1 / 0